chlorprothixene and Congenital Fissure of the Abdominal Cavity

chlorprothixene has been researched along with Congenital Fissure of the Abdominal Cavity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bateman, BT; Cesta, CE; Cohen, JM; Furu, K; Gissler, M; Hernandez-Diaz, S; Huybrechts, KF; Karlsson, P; Kieler, H; Leinonen, MK; Nørgaard, M; Pazzagli, L; Reutfors, J; Selmer, RM; Straub, L; Suarez, EA; Ulrichsen, SP; Zoega, H1

Other Studies

1 other study(ies) available for chlorprothixene and Congenital Fissure of the Abdominal Cavity

ArticleYear
Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US.
    JAMA psychiatry, 2023, 02-01, Volume: 80, Issue:2

    Topics: Abnormalities, Drug-Induced; Adult; Antipsychotic Agents; Chlorprothixene; Cohort Studies; Female; Gastroschisis; Heart Defects, Congenital; Humans; Infant; Olanzapine; Pregnancy; Scandinavian and Nordic Countries; Young Adult

2023